Urologische Klinik

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance () Branz A, Matek C, Lange F, Bahlinger V, Klümper N, Hölzel M, Strissel P, et al. Journal article Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlation () Bayerl N, Adams LC, Cavallaro AJ, Bäuerle T, Schlicht M, Wullich B, Hartmann A, et al. Journal article Pediatric kidney transplantation in Europe, a clinical snapshot pilot () Oomen L, Bootsma-Robroeks CM, Bouts AH, Carbonell Pradas M, Gander R, Kienzl-Wagner K, König P, et al. Journal article Tumor grade-titude: XGBoost radiomics paves the way for RCC classification (2025) Ellmann S, von Rohr F, Komina S, Bayerl N, Amann KU, Polifka I, Hartmann A, et al. Journal article Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations (2025) Schulmeyer C, Fasching P, Beckmann M, Häberle L, Golcher H, Goebell P, Pöschke P, Emons J Journal article xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis (2025) Wilhelm ED, Dankert JT, Wiesehöfer M, Wach S, Wagner M, Spahn M, Julio MKD, Wennemuth G Journal article Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis—a systematic review including meta-analysis of all comparative studies (2025) Wolff I, Büchner M, Hauner K, Wagenlehner F, Burchardt M, Abele-Horn M, Wullich B, et al. Journal article, Review article Comprehensive genomic characterization of early-stage bladder cancer (2025) Prip F, Lamy P, Lindskrog SV, Strandgaard T, Nordentoft I, Birkenkamp-Demtröder K, Birkbak NJ, et al. Journal article The utilization of a spare ureter to create a continent catheterizable channel to the bladder in pediatric patients (2025) Frank F, Wullich B, Hirsch-Koch K, Marcou M Journal article Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial (2025) Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, et al. Journal article